In a 33-year-old male alcoholic who stopped drinking 4 days ago, presents with vomiting, hyperbilirubinemia (bilirubin rising from 7 to 9 mg/dL), moderately elevated transaminases, normal INR, and impaired renal function (creatinine decreasing from 3.9 to 2.0 mg/dL) but is asymptomatic, what is the appropriate management?

Management of Alcoholic Hepatitis with Rising Bilirubin

This patient requires immediate initiation of prednisolone 40 mg daily for 28 days, aggressive nutritional support with enteral feeding targeting >21 kcal/kg/day, and close monitoring for infection and multi-organ failure.

Severity Assessment

Your patient has severe alcoholic hepatitis based on:

• Maddrey Discriminant Function (MDF): With bilirubin of 9 mg/dL and normal INR, the MDF is approximately 9 (below the threshold of 32 for "severe" by traditional criteria)
• However, the rising bilirubin from 7 to 9 despite 4 days of abstinence indicates lack of early clinical improvement, which is a poor prognostic sign 1
• The acute kidney injury (creatinine 3.9, now improving to 2.0) places him at high risk for hepatorenal syndrome and multi-organ failure 1, 2

Calculate the MELD score: With bilirubin 9, creatinine 2.0, and normal INR, his MELD is approximately 20-21, which indicates severe disease requiring treatment 2, 3.

Immediate Management Algorithm

1. Rule Out Contraindications to Corticosteroids 4, 2

Before starting treatment, obtain:

• Chest X-ray to exclude active tuberculosis
• Blood, urine, and ascitic fluid cultures (if ascites present) to exclude active infection
• Screen for hepatitis B (HBsAg) - active HBV is an absolute contraindication
• Ensure no active gastrointestinal bleeding
• Confirm creatinine is not worsening (>2.5 mg/dL is a relative contraindication)

2. Initiate Corticosteroid Therapy 4, 5

Start prednisolone 40 mg orally daily (or methylprednisolone 32 mg IV if unable to take oral medications). The most recent French guidelines 4 and AASLD guidance 3 strongly support this based on meta-analysis of 2,111 patients showing improved 1-month survival, though benefit disappears by 3 months.

Consider adding N-acetylcysteine: The combination of NAC (150 mg/kg loading dose, then 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours daily for 5 days) with corticosteroids showed improved 1- and 3-month survival in one randomized trial, though it did not meet the primary 6-month endpoint 4. Given the improving renal function, this combination may be particularly beneficial.

Do NOT use pentoxifylline: Recent evidence definitively shows it is ineffective and should no longer be prescribed 4.

3. Aggressive Nutritional Support 1, 2, 5

• Target >21 kcal/kg/day with high protein intake (1.2-1.5 g/kg/day)
• Enteral nutrition is superior to oral intake alone in severe alcoholic hepatitis
• Supplement with thiamine, folate, vitamin B12, vitamin D, and zinc 5
• If oral intake is inadequate, place a nasogastric tube for continuous feeding

4. Monitor Treatment Response with Lille Score at Day 7 4, 5, 3

Calculate the Lille score on day 7 of treatment:

• Lille score <0.45: Continue prednisolone for full 28 days (complete or partial responder)
• Lille score >0.45: Stop corticosteroids (null responder - no benefit and increased infection risk)

The Lille model incorporates age, bilirubin at day 0 and day 7, albumin, creatinine, and INR to predict 6-month mortality.

Critical Monitoring During Hospitalization

Watch for Multi-Organ Failure 2, 3

The improving creatinine (3.9→2.0) is encouraging, but:

• Monitor for SIRS (systemic inflammatory response syndrome) - associated with infection and multi-organ failure
• Avoid nephrotoxic drugs: NSAIDs, aminoglycosides, IV contrast
• Use diuretics cautiously - AKI is an early manifestation of multi-organ failure
• Daily assessment for infection (most common cause of treatment failure and death)

Infection Surveillance 2, 3, 6

Patients with alcoholic hepatitis have impaired neutrophil function despite leukocytosis:

• Low threshold for cultures if fever, worsening clinical status, or rising creatinine
• Consider empiric antibiotics if infection suspected (do not wait for culture results)
• Bacterial and fungal infections are the leading cause of death in corticosteroid-treated patients

Why This Patient Needs Treatment Despite MDF <32

Although the traditional MDF threshold is 32, this patient requires treatment because:

1. MELD score >20 is an alternative criterion for severe disease 2, 3
2. Rising bilirubin despite abstinence indicates ongoing severe inflammation 1
3. Recent acute kidney injury (creatinine 3.9) signals high risk for hepatorenal syndrome and multi-organ failure 1, 2
4. The combination of these factors predicts high 90-day mortality without intervention

Common Pitfalls to Avoid

Don't wait for symptoms to worsen: The patient being "asymptomatic" is misleading - severe biochemical derangement with rising bilirubin indicates active disease requiring intervention 2, 5.

Don't assume improving creatinine means low risk: The initial creatinine of 3.9 indicates he already developed AKI, placing him at high risk for recurrence and hepatorenal syndrome 1, 2.

Don't use pentoxifylline as alternative therapy: Multiple recent trials and the 2022 French guidelines definitively show it is ineffective 4.

Don't forget infection screening: Unrecognized infection is the most common reason for corticosteroid failure and accounts for 50-90% of deaths in treated patients 1, 2.

Long-Term Management

Alcohol abstinence is non-negotiable: Even with treatment response, 5-year survival is 80% with abstinence versus 50% with relapse 4.

Addiction medicine referral: Arrange follow-up with addiction specialist and consider pharmacotherapy (naltrexone or acamprosate) once acute illness resolves 1.

Liver transplant evaluation: If MELD remains >26 or Lille score >0.45, refer for early liver transplant evaluation if he has good insight into alcohol use disorder and adequate social support 2, 3.